Societe de Promotion Pharmaceutique du Maghreb S.A. (CBSE:PRO)
Morocco · Delayed Price · Currency is MAD 1,296.00
+73.00 (5.97%)
At close: Aug 28, 2026
CBSE:PRO Ratios and Metrics
Market cap in millions MAD. Fiscal year is January - December.
Millions MAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,300 | 1,500 | 950 | 1,000 | 1,068 | 1,140 | |
Market Cap Growth | -0.31% | 57.89% | -5.00% | -6.37% | -6.32% | 60.56% |
Enterprise Value | 1,352 | 1,593 | 1,018 | 971 | 942 | 969 |
Last Close Price | 1300.00 | 1500.00 | 950.00 | 1000.00 | 1028.95 | 1059.78 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 21.70 | 25.04 | 17.22 | 17.58 | 14.19 | 16.53 |
PS Ratio | 1.33 | 1.53 | 1.06 | 1.24 | 1.52 | 1.81 |
PB Ratio | 2.13 | 2.46 | 1.73 | 2.07 | 2.33 | 2.69 |
P/TBV Ratio | 2.16 | 2.49 | 1.76 | 2.11 | 2.38 | 2.76 |
P/FCF Ratio | - | - | 6.20 | 6.79 | 15.19 | 5.29 |
P/OCF Ratio | - | - | 6.20 | 6.79 | 5.36 | 4.61 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.38 | 1.63 | 1.13 | 1.21 | 1.34 | 1.54 |
EV/EBITDA Ratio | 12.53 | 14.76 | 8.26 | 8.62 | 6.58 | - |
EV/EBIT Ratio | 14.89 | 17.54 | 9.59 | 9.65 | 7.02 | 9.24 |
EV/FCF Ratio | - | - | 6.64 | 6.60 | 13.39 | 4.50 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.31 | 0.31 | 0.42 | 0.27 | 0.15 | 0.07 |
Debt / EBITDA Ratio | 1.76 | 1.76 | 1.85 | 1.16 | 0.48 | - |
Debt / FCF Ratio | - | - | 1.49 | 0.89 | 0.97 | 0.14 |
Net Debt / Equity Ratio | 0.09 | 0.09 | 0.20 | 0.14 | -0.12 | -0.48 |
Net Debt / EBITDA Ratio | 0.48 | 0.48 | 0.89 | 0.61 | -0.40 | - |
Net Debt / FCF Ratio | - | - | 0.72 | 0.47 | -0.81 | -0.95 |
Asset Turnover | 0.82 | 0.82 | 0.84 | 0.92 | 1.02 | 1.09 |
Inventory Turnover | 1.61 | 1.61 | 1.67 | 1.77 | 1.79 | 1.90 |
Quick Ratio | 1.09 | 1.09 | 1.20 | 1.00 | 1.39 | 2.33 |
Current Ratio | 2.00 | 2.00 | 2.15 | 1.74 | 2.40 | 3.30 |
Return on Equity (ROE) | 10.34% | 10.34% | 10.67% | 12.07% | 17.06% | 17.07% |
Return on Assets (ROA) | 4.77% | 4.77% | 6.20% | 7.20% | 12.16% | 11.29% |
Return on Invested Capital (ROIC) | 8.37% | 8.38% | 10.86% | 13.67% | 28.48% | 30.37% |
Return on Capital Employed (ROCE) | 11.00% | 11.00% | 13.20% | 16.70% | 24.90% | 22.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.61% | 3.99% | 5.81% | 5.69% | 7.05% | 6.05% |
FCF Yield | - | - | 16.14% | 14.72% | 6.59% | 18.91% |
Dividend Yield | 2.45% | - | - | - | 3.89% | 3.77% |
Payout Ratio | - | - | - | 70.30% | 53.14% | 43.50% |
Total Shareholder Return | 2.45% | - | - | - | 3.89% | 3.77% |